PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 44 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $192,000 | +120.7% | 8,301 | -2.8% | 0.00% | – |
| Q3 2020 | $87,000 | -33.1% | 8,539 | -2.2% | 0.00% | -100.0% |
| Q2 2020 | $130,000 | +28.7% | 8,733 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $101,000 | +36.5% | 8,307 | +78.8% | 0.00% | – |
| Q4 2019 | $74,000 | +27.6% | 4,645 | -0.8% | 0.00% | – |
| Q3 2019 | $58,000 | – | 4,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|